Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Wen

Showing results (1001-1010 of 1,547) with videos related to

Pageof 155
Sort By:
The American Journal of Surgical Pathology|June 11, 2021
PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical AssaysAnne Grabenstetter, Achim A Jungbluth, Denise Frosina, et al.
The Lancet. Oncology|March 29, 2023
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials ConferenceRifaquat Rahman, Mei-Yin C Polley, Laura Alder, et al.
Neuro-Oncology|January 17, 2019
Imaging and diagnostic advances for intracranial meningiomasRaymond Y Huang, Wenya Linda Bi, Brent Griffith, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Harvard Review of Psychiatry|November 9, 2018
Pain and Depression: A Systematic ReviewWaguih William IsHak, Raymond Y Wen, Lancer Naghdechi, et al.
Scientific Reports|April 8, 2021
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PETShiliang Huang, Joel E Michalek, David A Reardon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant gliomaDavid A Reardon, Morris D Groves, Patrick Y Wen, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Pageof 155

Showing results (1001-1010 of 1,547) with videos related to

Sort By:
Pageof 155
The American Journal of Surgical Pathology|June 11, 2021
PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical AssaysAnne Grabenstetter, Achim A Jungbluth, Denise Frosina, et al.
The Lancet. Oncology|March 29, 2023
Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials ConferenceRifaquat Rahman, Mei-Yin C Polley, Laura Alder, et al.
Neuro-Oncology|January 17, 2019
Imaging and diagnostic advances for intracranial meningiomasRaymond Y Huang, Wenya Linda Bi, Brent Griffith, et al.
Neuro-Oncology|October 16, 2025
Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant GliomasDavid Schiff, Xiaobu Ye, Jing Li, et al.
The Oncologist|December 15, 2010
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN studyJames J Vredenburgh, Timothy Cloughesy, Meghna Samant, et al.
Harvard Review of Psychiatry|November 9, 2018
Pain and Depression: A Systematic ReviewWaguih William IsHak, Raymond Y Wen, Lancer Naghdechi, et al.
Scientific Reports|April 8, 2021
Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and <sup>18</sup>F-FMISO PETShiliang Huang, Joel E Michalek, David A Reardon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant gliomaDavid A Reardon, Morris D Groves, Patrick Y Wen, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Neuro-Oncology|November 19, 2010
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumabMichael Prados, Timothy Cloughesy, Meghna Samant, et al.
Pageof 155